Male Breast Cancer Active Not Recruiting Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00513695Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerTreatment